Infectious diseases and the use of antibiotics in outpatients at the emergency department of the University Hospital of León, Nicaragua

International Journal of Infectious Diseases

Volumn 13, Issue 3, 2009, Pages 349-354

  den Engelsen, C ^a   van der Werf, C ^a   Matute, A J ^b   Delgado, E ^b   Schurink, C A M ^a   Hoepelman, A I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b National Autonomous University of Nicaragua   (Nicaragua)

Author keywords

Antibiotics; Guidelines; Infections; Nicaragua; Resistance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFADROXIL; CEFALEXIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; PROCAINE PENICILLIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMMON COLD; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIARRHEA; DRUG USE; EMERGENCY CARE; FEMALE; GASTROENTERITIS; HUMAN; INFECTION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NICARAGUA; OUTPATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; RESPIRATORY TRACT INFECTION; SINGLE DRUG DOSE; TONSILLITIS; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NICARAGUA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 64649101428     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.07.010     Document Type: Article

References (29)

1. Murray B.E. Can antibiotic resistance be controlled?. N Engl J Med 330 (1994) 1229-1230
2. Holmberg S.D., Solomon S.L., and Blake P.A. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 9 (1987) 1065-1078
3. French G.L. Clinical impact and relevance of antibiotic resistance. Adv Drug Deliv Rev 57 (2005) 1514-1527
4. Paladino J.A., Sunderlin J.L., Price C.S., and Schentag J.J. Economic consequences of antimicrobial resistance. Surg Infect (Larchmt) 3 (2002) 259-267
5. Okeke I.N., Laxminarayan R., Bhutta Z.A., Duse A.G., Jenkins P., O'Brien T.F., et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 5 (2005) 481-493
6. Kunin C.M. Resistance to antimicrobial drugs-a worldwide calamity. Ann Intern Med 118 (1993) 557-561
7. The World Factbook. Nicaragua. Available at: https://www.cia.gov/library/publications/the-world-factbook/geos/nu.html. (accessed September 2008).
8. Burke J.P. Antibiotic resistance-squeezing the balloon?. JAMA 280 (1998) 1270-1271
9. Okeke I.N., Klugman K.P., Bhutta Z.A., Duse A.G., Jenkins P., O'Brien T.F., et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 5 (2005) 568-580
10. Matute A.J., Brouwer W.P., Hak E., Delgado E., Alonso E., and Hoepelman I.M. Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua. Int J Antimicrob Agents 28 (2006) 423-427
11. Matute A.J., Hak E., Schurink C.A., McArthur A., Alonso E., Paniagua M., et al. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Int J Antimicrob Agents 23 (2004) 506-509
12. el Moussaoui R., de Borgie C.A., van den Broek P., Hustinx W.N., Bresser P., van den Berk G.E., et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 332 (2006) 1355
13. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
14. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 (2003) 377-382
15. Bisno A.L., Gerber M.A., Gwaltney Jr. J.M., Kaplan E.L., and Schwartz R.H. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 25 (1997) 574-583
16. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev 2006;CD000023.
17. Cheng A.C., McDonald J.R., and Thielman N.M. Infectious diarrhea in developed and developing countries. J Clin Gastroenterol 39 (2005) 757-773
18. Espinoza F., Paniagua M., Hallander H., Svensson L., and Strannegard O. Rotavirus infections in young Nicaraguan children. Pediatr Infect Dis J 16 (1997) 564-571
19. Guerrant R.L., Van Gilder T., Steiner T.S., Thielman N.M., Slutsker L., Tauxe R.V., et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32 (2001) 331-351
20. Manrique-Abril F.G., Diane B., Bello S.E., and Ospina J.M. Diarrhoea-causing agents in children aged less than five in Tunja Colombia. Rev Salud Publica (Bogota) 8 (2006) 88-97
21. Huilan S., Zhen L.G., Mathan M.M., Mathew M.M., Olarte J., Espejo R., et al. Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 69 (1991) 549-555
22. Mayatepek E., Seebass E., Hingst V., Kroeger A., and Sonntag H.G. Prevalence of enteropathogenic and enterotoxigenic Escherichia coli in children with and without diarrhoea in Esteli, Nicaragua. J Diarrhoeal Dis Res 11 (1993) 169-171
23. Binsztein N., Picandet A.M., Notario R., Patrito E., De Lesa M.E., De Petris A., et al. Antimicrobial resistance among species of Salmonella, Shigella, Escherichia, and Aeromonas isolated from children with diarrhea in 7 Argentinian centers. Rev Latinoam Microbiol 41 (1999) 121-126
24. Savola K.L., Baron E.J., Tompkins L.S., and Passaro D.J. Fecal leukocyte stain has diagnostic value for outpatients but not inpatients. J Clin Microbiol 39 (2001) 266-269
25. DuBois D., Binder L., and Nelson B. Usefulness of the stool Wright's stain in the emergency department. J Emerg Med 6 (1988) 483-486
26. Gerber M.A., Tanz R.R., Kabat W., Dennis E., Bell G.L., Kaplan E.L., et al. Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA 277 (1997) 899-903
27. Gieseker K.E., Mackenzie T., Roe M.H., and Todd J.K. Comparison of two rapid Streptococcus pyogenes diagnostic tests with a rigorous culture standard. Pediatr Infect Dis J 21 (2002) 922-927
28. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.A., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
29. Lomas J., Anderson G.M., Domnick-Pierre K., Vayda E., Enkin M.W., and Hannah W.J. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 321 (1989) 1306-1311